This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

UE2343

University of Edinburgh

Drug Names(s): UE-2343

Description: UE2343 is a potent oral inhibitor of 11-beta-HSD1.

Deal Structure: UE2343 is being developed by the University of Edinburgh and Argenta, a drug discovery arm of Galapagos NV (acquired in February 2010).

Partners: Galapagos NV


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug